MedPath

A randomised controlled trial of tea tree oil (5%) body wash versus standard body wash to prevent colonisation with methicillin-resistant Staphylococcus aureus in critically ill adults

Completed
Conditions
Critical illness
Methicillin-Resistant Staphylococcus Aureus (MRSA)
Infections and Infestations
Staphylococcus infection
Registration Number
ISRCTN65190967
Lead Sponsor
Belfast Health and Social Care Trust (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
1080
Inclusion Criteria

Patients admitted to the Intensive Care Unit (ICU) during the study period will be eligible for inclusion in the study.

Exclusion Criteria

1. Aged less than 16 years
2. Those patients who are known to be colonised at the time of admission
3. Patients who on admission are unlikely to remain in the Respiratory Intensive Care Unit (RICU) for at least 48 hours
4. Patients who are recruited, whose pre-intervention MRSA screening tests are subsequently found to be positive, will be withdrawn from the study
5. Consent declined
6. Known sensitivity to TTO

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ew MRSA colonisation during the inpatient episode in RICU, as defined by detection of MRSA by conventional culture methods in screening swabs of nose and groin, or in clinical specimens processed by the laboratory in the course of normal clinical care. This will be measured on discharge from the ICU.
Secondary Outcome Measures
NameTimeMethod
All measured on discharge from the ICU:<br>1. Cost-effectiveness of regular use of 5% TTO body wash in this context<br>2. MRSA bacteraemia rates<br>3. Consumption of antibiotics used for the treatment of MRSA infection<br>4. Changes in the Sequential Organ Failure Assessment (SOFA) score during ICU stay
© Copyright 2025. All Rights Reserved by MedPath